KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Interest Coverage Ratio (2016 - 2020)

Nektar Therapeutics has reported Interest Coverage Ratio over the past 11 years, most recently at 120.11 for Q2 2020.

  • Quarterly results put Interest Coverage Ratio at 120.11 for Q2 2020, down 466.17% from a year ago — trailing twelve months through Mar 2021 was 619.59 (down 2948.56% YoY), and the annual figure for FY2020 was 62.05, down 200.5%.
  • Interest Coverage Ratio for Q2 2020 was 120.11 at Nektar Therapeutics, down from 21.54 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for NKTR hit a ceiling of 180.8 in Q2 2018 and a floor of 120.11 in Q2 2020.
  • Median Interest Coverage Ratio over the past 5 years was 13.16 (2017), compared with a mean of 7.09.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 5977.31% in 2016 and later surged 2066.6% in 2018.
  • Nektar Therapeutics' Interest Coverage Ratio stood at 5.79 in 2016, then rose by 26.33% to 4.27 in 2017, then plummeted by 334.1% to 18.52 in 2018, then decreased by 9.05% to 20.2 in 2019, then tumbled by 494.63% to 120.11 in 2020.
  • The last three reported values for Interest Coverage Ratio were 120.11 (Q2 2020), 21.54 (Q1 2020), and 20.2 (Q4 2019) per Business Quant data.